Thoughts on UHC’s New T2DM-focused Digital Care Platform (Level2); Implications to Dexcom and Other Coaching Solutions
Last week, UnitedHealthcare launched a new program, called Level2 (view website here), for T2DM patients. The program combines wearable technology from Dexcom and Fitbit with personalized support tools, including coaching. A Level2 pilot is currently being expanded to 27 states and Washington, D.C. Later this year, UHC intends to make Level2 more broadly available for free to its 230,000 eligible members. Below, FENIX provides an overview of the Level2 program, potential insight into UHC’s motivation to create Level2, implications to Dexcom, and thoughts on the potential impact on similar solutions from companies like Livongo, Onduo, Omada, Welldoc, etc.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.